WEEDCanopy Growth Corporation
1.310CAD-2.24%Mkt Cap: 427.80M $P/E:

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and …

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$65.19BUSDP/E 23.7
UTHR
United Therapeutics Corporation
$22.46BUSDP/E 19.5
VTRS
Viatris Inc.
$20.18BUSD
NBIX
Neurocrine Biosciences, Inc.
$17.25BUSDP/E 26.4
SOBI
Swedish Orphan Biovitrum AB (publ)
$15.47BUSDP/E 179.2
IPN
Ipsen S.A.
$14.18BUSDP/E 29.7
ELAN
Elanco Animal Health Incorporated
$12.96BUSD
KRK
Krka, d. d.
$8.93BUSDP/E 22.7
HIMS
Hims & Hers Health, Inc.
$7.80BUSD
LNTH
Lantheus Holdings, Inc.
$6.84BUSDP/E 25.1
LQDA
Liquidia Corporation
$6.69BUSDP/E 442.8
AMRX
Amneal Pharmaceuticals, Inc.
$5.76BUSDP/E 48.8
SFZN
Siegfried Holding AG
$3.65BUSDP/E 19.0
HIK
Hikma Pharmaceuticals PLC
$3.55BUSDP/E 11.3
ROVI
Laboratorios Farmaceuticos Rovi, S.A.
$2.99BUSDP/E 20.9
SUPN
Supernus Pharmaceuticals, Inc.
$2.80BUSD
ALM
Almirall, S.A.
$2.52BUSDP/E 56.0
DMP
Dermapharm Holding SE
$2.35BUSDP/E 16.3
PBH
Prestige Consumer Healthcare Inc.
$2.40BUSDP/E 12.9
BCRX
BioCryst Pharmaceuticals, Inc.
$2.31BUSD
FAGR
Fagron NV
$1.92BUSDP/E 19.4
AMLX
Amylyx Pharmaceuticals, Inc.
$1.89BUSD
ANIP
ANI Pharmaceuticals, Inc.
$1.86BUSDP/E 21.0
PPGN
PolyPeptide Group AG
$1.71BUSD
BHC
Bausch Health Companies Inc.
$1.89BUSD
HROW
Harrow, Inc.
$1.67BUSD
FAE
Faes Farma, S.A.
$1.48BUSDP/E 17.5
XERS
Xeris Biopharma Holdings, Inc.
$1.50BUSDP/E 124.1
PAHC
Phibro Animal Health Corporation
$1.40BUSDP/E 14.8
BIOG-B
BioGaia AB (publ)
$1.12BUSDP/E 35.4
COLL
Collegium Pharmaceutical, Inc.
$1.18BUSDP/E 17.6
ECILC
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.
$1.23BUSD
CRON
Cronos Group Inc.
$1.06BUSDP/E Infinity
ETON
Eton Pharmaceuticals, Inc.
$1.02BUSD
PCRX
Pacira BioSciences, Inc.
$1.01BUSDP/E 196.9
BIOA
BioAge Labs, Inc.
$985.07MUSD
VETO
Vetoquinol SA
$918.60MUSDP/E 14.7
PHN
Pharmanutra S.p.A.
$873.22MUSDP/E 38.1
AMPH
Amphastar Pharmaceuticals, Inc.
$875.69MUSDP/E 12.0
ESPR
Esperion Therapeutics, Inc.
$819.46MUSDP/E Infinity
EVT
Evotec SE
$668.29MUSD
GUD
Knight Therapeutics Inc.
$692.84MUSDP/E 161.5
IRWD
Ironwood Pharmaceuticals, Inc.
$637.05MUSDP/E 6.2
BOI
Boiron SA
$505.77MUSDP/E 14.3
AQST
Aquestive Therapeutics, Inc.
$494.34MUSD
AGY
Allergy Therapeutics plc
$447.41MUSD
EBS
Emergent BioSolutions Inc.
$396.78MUSD
AKBA
Akebia Therapeutics, Inc.
$375.56MUSD
EOLS
Evolus, Inc.
$370.76MUSD
SCYX
SCYNEXIS, Inc.
$355.90MUSD
ORGO
Organogenesis Holdings Inc.
$343.56MUSD
DEVA
Deva Holding A.S.
$357.30MUSD
ATB
Antibiotice S.A.
$320.48MUSDP/E 43.7
BIO
Biofarm S.A.
$294.94MUSDP/E 15.2
CPH
Cipher Pharmaceuticals Inc.
$303.08MUSDP/E 9.7
LAVI
Lavipharm S.A.
$273.62MUSDP/E 49.1
TKNO
Alpha Teknova, Inc.
$285.23MUSD
ANCR
Animalcare Group plc
$250.29MUSDP/E 47.6
SIGA
SIGA Technologies, Inc.
$255.34MUSDP/E 12.7
RJF
Laboratorio Reig Jofre, S.A.
$236.39MUSDP/E 53.0
CLN
Celon Pharma S.A.
$206.95MUSDP/E 10.3
ANIK
Anika Therapeutics, Inc.
$210.49MUSD
DERM
Journey Medical Corporation
$195.77MUSD
LFCR
Lifecore Biomedical, Inc.
$185.67MUSD
XLY
Auxly Cannabis Group Inc.
$182.70MUSDP/E 8.8
ACB
Aurora Cannabis Inc.
$164.20MUSD
PHO
Photocure ASA
$143.26MUSDP/E 18.3
CRDL
Cardiol Therapeutics Inc.
$146.07MUSD
EAPI
Euroapi S.A.
$133.59MUSD
OGI
Organigram Global Inc.
$126.10MUSD
RX
BioSyent Inc.
$119.66MUSDP/E 18.6
CPIX
Cumberland Pharmaceuticals Inc.
$114.77MUSD
VISTN
Vistin Pharma ASA
$83.73MUSDP/E 12.0
HLS
HLS Therapeutics Inc.
$94.75MUSD
STX
Shield Therapeutics plc
$72.66MUSD
NANEXA
Nanexa AB (publ)
$67.25MUSD
TLPH
Talphera, Inc.
$70.06MUSD
EQL
EQL Pharma AB
$62.42MUSDP/E 52.6
EAH
ECO Animal Health Group plc
$63.44MUSDP/E 21.8
ORX
Orexo AB (publ)
$60.48MUSD
CTOR
Citius Oncology, Inc.
$63.41MUSD
CINPHA
Cinclus Pharma Holding AB (publ)
$53.86MUSD
ENZY
Enzymatica AB (publ)
$50.62MUSD
AB
AB Science S.A.
$49.37MUSD
DB
Decibel Cannabis Company Inc.
$48.31MUSD
MOB
Moberg Pharma AB (publ)
$42.20MUSD
TRILC
Turk Ilac Ve Serum Sanayi Anonim Sirketi
$41.16MUSD
MLC
Malin Corporation plc
$33.86MUSDP/E Infinity
PXS
Provexis plc
$31.75MUSD
LABS
MediPharm Labs Corp.
$27.85MUSD
BTAI
BioXcel Therapeutics, Inc.
$26.87MUSD
TXMD
TherapeuticsMD, Inc.
$23.61MUSDP/E 204.0
AYTU
Aytu BioPharma, Inc.
$23.18MUSD
RMTI
Rockwell Medical, Inc.
$22.62MUSD
ROMJ
Rubicon Organics Inc.
$22.15MUSD
KLAR
Klaria Pharma Holding AB (publ.)
$18.56MUSD
VM
Voyageur Pharmaceuticals Ltd.
$17.65MUSD
B8FK
Biofrontera AG
$14.93MUSD
MEDIC
Medicon Hellas S.A.
$13.84MUSDP/E 16.8
BFRI
Biofrontera Inc.
$14.21MUSD
CABR
Caring Brands, Inc.
$11.64MUSD
AVCN
Avicanna Inc.
$11.91MUSD
APUS
Apimeds Pharmaceuticals US, Inc.
$9.88MUSD
VIVE
Vivesto AB
$8.99MUSD
PCLO
PharmaCielo Ltd.
$8.21MUSD
MPH
Medicure Inc.
$8.13MUSD
NUTEX
NUTEX Investments Public Limited Company
$6.05MUSDP/E 3.7
STENO
Stenocare A/S
$6.17MUSD
YCBD
cbdMD, Inc.
$6.48MUSDP/E 0.3
SNOA
Sonoma Pharmaceuticals, Inc.
$5.84MUSD
MUSH
Mercanto Holdings Inc.
$5.46MUSDP/E Infinity
EGRX
Eagle Pharmaceuticals, Inc.
$3.29MUSDP/E 1.6
ERMA
Enorama Pharma AB (publ)
$2.01MUSD
GABA
Gabather AB (publ)
$1.93MUSD
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
$2.08MUSDP/E 35.5
CANB
CanadaBis Capital Inc.
$1.54MUSD
GENX
Genix Pharmaceuticals Corporation
$668.8KUSD
PTPI
Petros Pharmaceuticals, Inc.
$173.7KUSDP/E 0.0
CLVR
Clever Leaves Holdings Inc.
$175USD
Indicators:|

Key Statistics

Company
Market Cap427.80M $
Enterprise Value339.45M $
Revenue (TTM)207.27M $
Gross Profit50.74M $
Net Income (TTM)-191.47M $
Revenue/Share0.6955 USD
Last Price1.310 CAD
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees1.1K
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA1380351009
Valuation
P/E (Trailing)
P/E (Forward)-7.71
PEG
EV/EBITDA-17.42
EV/Revenue1.64
P/S2.06
P/B0.64
EPS (TTM)-0.88
EPS (Forward)-0.17
52W Range
1.1806% of range3.280
52W High3.280 CAD
52W Low1.180 CAD
Profitability
Gross Margin24.48%
Oper. Margin-24.70%
EBITDA Margin-9.40%
Profit Margin-92.38%
ROE-37.69%
ROA-23.50%
Growth
Revenue Growth9.60%
Earnings Growth
Cash Flow & Leverage
Operating CF-46.47M $
CapEx (TTM)4.34M $
FCF Margin5.67%
FCF Yield2.75%
Net Debt-63.30M $
Net Debt/EBITDA3.25
Balance Sheet
Debt/Equity0.40
Current Ratio3.34
Quick Ratio2.54
Book Value/Sh2.059 CAD
Cash/Share0.8660 CAD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 CAD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:10
Split DateDec 20, 2023
Analyst Consensus
Rating2.6 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.020 CAD
Upside (mean)+54.2%
Target Range0.9400 CAD5.000 CAD
CAD0.9400+54.2% to meanCAD5.000
# Analysts7
Ownership
Shares Out.422.15M
Float421.75M
Insiders0.25%
Institutions7.90%
Short Interest
Short Ratio12.6d
Short % Float3.91%
Short % Out.3.91%
Shares Short16.51M
Short (prev mo.)15.05M
Technical
SMA 501.423 (-8.0%)
SMA 2001.587 (-17.4%)
Beta2.42
S&P 52W Chg19.63%
Avg Vol (30d)1.15M
Avg Vol (10d)634.17K
Technical Indicators
RSI (14)38.9
MACD-0.0216
MACD Signal-0.0198
MACD Hist.-0.0018
BB Upper1.435 CAD
BB Middle1.364 CAD
BB Lower1.293 CAD
BB Width10.48%
ATR (14)0.0499 CAD
Vol Ratio (20d)1.03x